CA2689656A1 - System, method and biosensor apparatus for data communications with a personal data assistant - Google Patents
System, method and biosensor apparatus for data communications with a personal data assistant Download PDFInfo
- Publication number
- CA2689656A1 CA2689656A1 CA2689656A CA2689656A CA2689656A1 CA 2689656 A1 CA2689656 A1 CA 2689656A1 CA 2689656 A CA2689656 A CA 2689656A CA 2689656 A CA2689656 A CA 2689656A CA 2689656 A1 CA2689656 A1 CA 2689656A1
- Authority
- CA
- Canada
- Prior art keywords
- processing device
- block
- biosensor
- indicated
- biosensor apparatus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
Abstract
A system, method and biosensor apparatus are provided for data communications with a personal data assistant. The bio-sensor apparatus includes a sensor for receiving a user sample to be measured and a microcontroller for performing a predefined test sequence for measuring a predefined parameter value. An interface logic block is coupled to the microcontroller for communicating the predefined parameter data value to the personal data assistant. The personal data assistant provides an operator interface, data management and analysis of biosensor results.
Description
SYSTEM, METHOD AND BIOSENSOR APPARATUS FOR DATA
COMMUNICATIONS WITH A PERSONAL DATA ASSISTANT
Field of the Invention The present invention generally relates to a bio-sensor, and, more particularly, to a new and improved system, method and biosensor apparatus for data communi-cations with a personal data assistant.
Description of the Prior Art The quantitative determination of analytes in body fluids is of great importance in the diagnoses and main-tenance of certain physiological abnormalities. For ex-ample lactate, cholesterol and bilirubin should be moni-tored in certain individuals. Inparticular, the deter-mination of glucose in body fluids is of great impor-tance to diabetic individuals who must frequently check the level of glucose in their body fluids as a means of regulating. the glucose intake in their diets, insulin intake and events. While the remainder of the disclo-sure herein will be directed towards the determination of glucose, it is to be understood that the procedure and apparatus of this invention can be used with other diagnostic systems.
Diagnostic systems, such as, blood glucose systems include a biosensor apparatus used to calculate the ac-tual glucose value based on a measured output, such as, current or color, and the known reactivity of the rea-gent sensing element used to perform the test. The test results typically are displayed to the user and stored in a memory in the biosensor apparatus.
One known personal data assistant is a PalmTM hand-held personal data assistant. It is desirable to pro-
COMMUNICATIONS WITH A PERSONAL DATA ASSISTANT
Field of the Invention The present invention generally relates to a bio-sensor, and, more particularly, to a new and improved system, method and biosensor apparatus for data communi-cations with a personal data assistant.
Description of the Prior Art The quantitative determination of analytes in body fluids is of great importance in the diagnoses and main-tenance of certain physiological abnormalities. For ex-ample lactate, cholesterol and bilirubin should be moni-tored in certain individuals. Inparticular, the deter-mination of glucose in body fluids is of great impor-tance to diabetic individuals who must frequently check the level of glucose in their body fluids as a means of regulating. the glucose intake in their diets, insulin intake and events. While the remainder of the disclo-sure herein will be directed towards the determination of glucose, it is to be understood that the procedure and apparatus of this invention can be used with other diagnostic systems.
Diagnostic systems, such as, blood glucose systems include a biosensor apparatus used to calculate the ac-tual glucose value based on a measured output, such as, current or color, and the known reactivity of the rea-gent sensing element used to perform the test. The test results typically are displayed to the user and stored in a memory in the biosensor apparatus.
One known personal data assistant is a PalmTM hand-held personal data assistant. It is desirable to pro-
-2-vide a mechanism to enable the use a personal data as-sistant with a biosensor apparatus to eliminate the need for a user to manually enter data or go through a hook-up process to download measurements from a separate blood glucose monitor. A need exists for an efficient and effective mechanism to enable a biosensor to commu-nicate with a personal data assistant. It is desirable to provide an improved method for storing and displaying information for use by a diabetic patient and also al-lows the user to augment stored glucose results by en-tering and storing insulin amounts and time as well as other relevant markers, for example, logbook capability.
Summary of the Invention An important object of the present, invention is to provide a new and improved system, method and biosensor apparatus for data communications with a personal data assistant. Other important objects of the present in-vention are to provide such system, method and apparatus that eliminates or minimizes the need for user interac-tion; and to provide such method and apparatus substan-tially without negative effect; and that overcome some disadvantages of prior art arrangements.
In brief, a system, method and biosensor apparatus are provided for communications with a personal data as-sistant. The biosensor apparatus includes-a sensor for receiving a user sample to be measured and a microcon-troller for performing a predefined test sequence for measuring a predefined parameter value. An interface logic block is coupled to the microcontroller for commu-nicating with the personal data assistant. The personal data assistant includes an interface logic block for communicating with the biosensor apparatus. The per-sonal data assistant provides an operator interface, data management and analysis of biosensor results.
Summary of the Invention An important object of the present, invention is to provide a new and improved system, method and biosensor apparatus for data communications with a personal data assistant. Other important objects of the present in-vention are to provide such system, method and apparatus that eliminates or minimizes the need for user interac-tion; and to provide such method and apparatus substan-tially without negative effect; and that overcome some disadvantages of prior art arrangements.
In brief, a system, method and biosensor apparatus are provided for communications with a personal data as-sistant. The biosensor apparatus includes-a sensor for receiving a user sample to be measured and a microcon-troller for performing a predefined test sequence for measuring a predefined parameter value. An interface logic block is coupled to the microcontroller for commu-nicating with the personal data assistant. The personal data assistant includes an interface logic block for communicating with the biosensor apparatus. The per-sonal data assistant provides an operator interface, data management and analysis of biosensor results.
-3-Brief Description of the Drawings The present invention together with the above and other objects and advantages may best be understood from the following detailed description of the preferred em-bodiments of the invention illustrated in the drawings, wherein:
FIG. 1 is a block diagram representation of a sys-tem including a biosensor apparatus and a personal data assistant in accordance with the present invention;
FIG. 2 is a block diagram representation of a bio-sensor apparatus in accordance with the present inven-tion of the system of FIG. 1;
FIG. 3 is a block diagram representation of a per-sonal data assistant used with the biosensor apparatus of FIGS. 1 and 2 in accordance with the present inven-tion;
FIG. 4 is a flow chart illustrating exemplary user interface operations of the personal data assistant of FIG. 3 in the system of FIG. 1 in accordance with the present invention;
FIG. 5 is a flow chart illustrating exemplary se-quential timing steps performed by the biosensor appara-tus of FIGS. 1 and 2 in accordance with the present in-vention;
FIGS. 6-13 are flow charts illustrating exemplary sequential steps performed by the personal data assis-tant of FIGS. 1 and 3 in accordance with the present in-vention; and
FIG. 1 is a block diagram representation of a sys-tem including a biosensor apparatus and a personal data assistant in accordance with the present invention;
FIG. 2 is a block diagram representation of a bio-sensor apparatus in accordance with the present inven-tion of the system of FIG. 1;
FIG. 3 is a block diagram representation of a per-sonal data assistant used with the biosensor apparatus of FIGS. 1 and 2 in accordance with the present inven-tion;
FIG. 4 is a flow chart illustrating exemplary user interface operations of the personal data assistant of FIG. 3 in the system of FIG. 1 in accordance with the present invention;
FIG. 5 is a flow chart illustrating exemplary se-quential timing steps performed by the biosensor appara-tus of FIGS. 1 and 2 in accordance with the present in-vention;
FIGS. 6-13 are flow charts illustrating exemplary sequential steps performed by the personal data assis-tant of FIGS. 1 and 3 in accordance with the present in-vention; and
-4-FIGS. 14-16 are flow charts illustrating exemplary sequential steps performed by the biosensor apparatus of FIGS. 1 and 2 in accordance with the present invention.
Detailed Description of the Preferred Embodiments Having reference now to the drawings, in FIG. 1 there is illustrated a system designated as a whole by the reference character 10 and arranged in accordance with principles of the present invention. System 10 in-cludes a biosensor apparatus 100 used together with a personal data assistant 200. Personal data assistant 200 also is adapted for bi-directional communications with a host computer 300.
In FIG. 2 there is illustrated the biosensor appa-ratus designated as a whole by the reference character 100 and arranged in accordance with principles of the present invention. Biosensor apparatus 100 includes a data acquisition circuit generally designated by the reference character 102 and a microcontroller section generally designated by the reference character 104.
Data acquisition circuit 102 includes a sensor 106 for receiving a blood sample from a user for performing a blood glucose test. A sensor drive input and a current input are applied to the sensor 106. One of a pair of electrostatic discharge suppressors 108 and 109 is cou-pled respectively to the sensor drive input and the cur-rent input. A programmable voltage source 110 is cou-pled to an analog switching device 112. A voltage ref-erence VREF and an analog ground or common ACOM are ap-plied to the programmable voltage source 110. Analog switching device 112 is also coupled to a reference re-sistor 114 and a thermistor 116. Both the reference re-sistor 114 and the thermistor 116 are also connected to a transimpedance amplifier 118. Analog switching device 112 couples a drive voltage or open to the sensor 106 at
Detailed Description of the Preferred Embodiments Having reference now to the drawings, in FIG. 1 there is illustrated a system designated as a whole by the reference character 10 and arranged in accordance with principles of the present invention. System 10 in-cludes a biosensor apparatus 100 used together with a personal data assistant 200. Personal data assistant 200 also is adapted for bi-directional communications with a host computer 300.
In FIG. 2 there is illustrated the biosensor appa-ratus designated as a whole by the reference character 100 and arranged in accordance with principles of the present invention. Biosensor apparatus 100 includes a data acquisition circuit generally designated by the reference character 102 and a microcontroller section generally designated by the reference character 104.
Data acquisition circuit 102 includes a sensor 106 for receiving a blood sample from a user for performing a blood glucose test. A sensor drive input and a current input are applied to the sensor 106. One of a pair of electrostatic discharge suppressors 108 and 109 is cou-pled respectively to the sensor drive input and the cur-rent input. A programmable voltage source 110 is cou-pled to an analog switching device 112. A voltage ref-erence VREF and an analog ground or common ACOM are ap-plied to the programmable voltage source 110. Analog switching device 112 is also coupled to a reference re-sistor 114 and a thermistor 116. Both the reference re-sistor 114 and the thermistor 116 are also connected to a transimpedance amplifier 118. Analog switching device 112 couples a drive voltage or open to the sensor 106 at
-5-the sensor drive input. The transimpedance amplifier 118 coupled to the sensor current input applies an input to an analog-to-digital converter (ADC) with threshold detection 120. A voltage reference VREF and an analog ground or common ACOM are applied to the ADC with threshold detection 120. A gain resistor 122 and a par-allel, series connected shunt 124 and current shunt 126 are connected across the transimpedance amplifier 118.
Data acquisition circuit 102 includes a voltage refer-ence and distribution block 128 to supply reference voltages to the rest of the system. The sensor detect input connects to the microcontroller 130.
Microcontroller section 104 includes a microcon-troller 130 receiving a voltage supply VCC input from the voltage reference and distribution block 128. A me-ter and communications program 131 is used with the mi-crocontroller 130 in accordance with features of the preferred embodiment. Microcontroller is coupled to the programmable voltage source 110 and the ADC with thresh-old detection 120. Microcontroller section 104 includes an interface logic block 132 coupled between the micro-controller 130 and a module interface connector 134 ena-bling communications with the personal data assistant 200 of FIG. 2. Microcontroller 130 contains suitable programming to perform the methods of the invention as illustrated in FIGS. 5 and 14-16.
Referring to FIG. 3, the personal data assistant (PDA) 200 includes a processor section 202 and a user interface 204. The processor section 202 includes a processor 206 together with a biosensor program 207 in accordance with features of the preferred embodiment.
Processor section 202 contains suitable programming to perform the methods of the invention as illustrated in FIGS. 4 and 6-13. The processor section 202 includes a PDA interface connector 208 enabling communications with
Data acquisition circuit 102 includes a voltage refer-ence and distribution block 128 to supply reference voltages to the rest of the system. The sensor detect input connects to the microcontroller 130.
Microcontroller section 104 includes a microcon-troller 130 receiving a voltage supply VCC input from the voltage reference and distribution block 128. A me-ter and communications program 131 is used with the mi-crocontroller 130 in accordance with features of the preferred embodiment. Microcontroller is coupled to the programmable voltage source 110 and the ADC with thresh-old detection 120. Microcontroller section 104 includes an interface logic block 132 coupled between the micro-controller 130 and a module interface connector 134 ena-bling communications with the personal data assistant 200 of FIG. 2. Microcontroller 130 contains suitable programming to perform the methods of the invention as illustrated in FIGS. 5 and 14-16.
Referring to FIG. 3, the personal data assistant (PDA) 200 includes a processor section 202 and a user interface 204. The processor section 202 includes a processor 206 together with a biosensor program 207 in accordance with features of the preferred embodiment.
Processor section 202 contains suitable programming to perform the methods of the invention as illustrated in FIGS. 4 and 6-13. The processor section 202 includes a PDA interface connector 208 enabling communications with
-6-the biosensor apparatus 100. An interface logic block 210 is coupled between the PDA interface connector 208 and the processor 206. An IR interface 212 and a RF in-.terface 214 are coupled to the processor 206 for commu-nications with a host computer 300. It should be under-stood that the principles of the present invention are not limited to the use of connectors 134 and 208 of FIGS. 2 and 3. For example, the IR interface 212 could be used with an IR port (not shown) on the biosensor ap-paratus 100 for communications between the biosensor ap-paratus 100 and the PDA 200.
PDA user interface 204 includes a touch sensitive display 220 coupled to the processor 206. PDA user in-terface 204 includes a stylus 222 for providing user se-lections. PDA user interface 204 includes a plurality of switches or buttons 224 for providing user selec-tions.
In accordance with the invention, the desired sys-tem behavior includes that the user attaches the biosen-sor apparatus 100 to the PDA 200; the users inserts a strip into the biosensor apparatus 100; the PDA 200 turns on if it is off; or if it is on immediately runs the biosensor program. Then the biosensor apparatus 100 and meter and communications program 131, and PDA 200 and biosensor program 207, run in test mode.
To enable the biosensor apparatus 100 to wake up the PDA 200 when a strip is inserted, an interrupt line of PDA 200 is used. The PDA Modem Hotsync program also uses this interrupt line. Therefore the PDA Modem Hot-sync button is re-mapped to run the biosensor program 207 and not the Modem Hotsync program. This re-mapping is done by setting the modem hotsync button in the Pref-erences program, a PDA supplied application. This re-mapping is performed at installation time. The default
PDA user interface 204 includes a touch sensitive display 220 coupled to the processor 206. PDA user in-terface 204 includes a stylus 222 for providing user se-lections. PDA user interface 204 includes a plurality of switches or buttons 224 for providing user selec-tions.
In accordance with the invention, the desired sys-tem behavior includes that the user attaches the biosen-sor apparatus 100 to the PDA 200; the users inserts a strip into the biosensor apparatus 100; the PDA 200 turns on if it is off; or if it is on immediately runs the biosensor program. Then the biosensor apparatus 100 and meter and communications program 131, and PDA 200 and biosensor program 207, run in test mode.
To enable the biosensor apparatus 100 to wake up the PDA 200 when a strip is inserted, an interrupt line of PDA 200 is used. The PDA Modem Hotsync program also uses this interrupt line. Therefore the PDA Modem Hot-sync button is re-mapped to run the biosensor program 207 and not the Modem Hotsync program. This re-mapping is done by setting the modem hotsync button in the Pref-erences program, a PDA supplied application. This re-mapping is performed at installation time. The default
-7-mapping of the hotsync modem button is to run the Modem Hotsync program.
In order to allow a user to hotsync their PDA 200 with a modem and then to use the biosensor program 207 a check in the biosensor communications program is per-formed to see if the test module biosensor apparatus 100 is attached to the PDA 200 or a modem is attached to the PDA 200. When the biosensor program 207 starts up by the insertion of a test sensor strip, a check is done to see if the biosensor apparatus 100 is attached. If the biosensor apparatus 100 is attached then the biosensor communications program continues in Test mode. If the biosensor apparatus 100 is not attached then the biosen-sor program 207 terminates and the Modem Hotsync program is initiated.
After installation of the biosensor program 207, if the user modifies the mapping of the modem hotsync but-ton (by the Preferences program) or a hard reset is done on the PDA 200 (which puts the modem hotsync button back to its default) the biosensor program 207 will not run when a user inserts a strip into the test module at-tached to the PDA 200. The logbook portion of the bio-sensor program 207 will still run because this program is started when the user taps on a predefined icon. The logbook portion is not started via the interrupt line.
If the user repeatedly inserts and removes a sensor without applying sample, the system will handle these multiple inserts thereby preventing the program from running multiple times.
FIG. 4 illustrate exemplary user interface opera-tions of system 10 including the biosensor apparatus 100 of FIG. 1 and the personal data assistant 200 of FIG. 2 in accordance with the present invention. A logbook
In order to allow a user to hotsync their PDA 200 with a modem and then to use the biosensor program 207 a check in the biosensor communications program is per-formed to see if the test module biosensor apparatus 100 is attached to the PDA 200 or a modem is attached to the PDA 200. When the biosensor program 207 starts up by the insertion of a test sensor strip, a check is done to see if the biosensor apparatus 100 is attached. If the biosensor apparatus 100 is attached then the biosensor communications program continues in Test mode. If the biosensor apparatus 100 is not attached then the biosen-sor program 207 terminates and the Modem Hotsync program is initiated.
After installation of the biosensor program 207, if the user modifies the mapping of the modem hotsync but-ton (by the Preferences program) or a hard reset is done on the PDA 200 (which puts the modem hotsync button back to its default) the biosensor program 207 will not run when a user inserts a strip into the test module at-tached to the PDA 200. The logbook portion of the bio-sensor program 207 will still run because this program is started when the user taps on a predefined icon. The logbook portion is not started via the interrupt line.
If the user repeatedly inserts and removes a sensor without applying sample, the system will handle these multiple inserts thereby preventing the program from running multiple times.
FIG. 4 illustrate exemplary user interface opera-tions of system 10 including the biosensor apparatus 100 of FIG. 1 and the personal data assistant 200 of FIG. 2 in accordance with the present invention. A logbook
-8-block 400 is provided for displaying historical data and a graphs block 402 enables analysis of results data and graphical display of the historical data. A download external meter data block 404 enables downloading of data stored in the biosensor apparatus 100. A delete records block 406 enables the user to delete data rec-.ords. A change user preferences block 408 enables the user to enter and update user preferences. An about block 410 is provided for displaying system information to the user. An edit/enter user-entered records block .412 is provided for the user to enter and edit records, such as insulin, event, blood, and the like. An edit meter records block 414 is provided for the user to edit records, meter and module records, such as markers, and the like. A waiting for application of sample block 416 enables the user to process a change in a code F# for a test strip and start a test. A test countdown block 418 displays a countdown for the user after a sample is ap-plied to the test strip in the biosensor apparatus 100.
FIG. 5 illustrates exemplary sequential timing steps performed by the biosensor apparatus 100 in accor-dance with the present invention. In accordance with features of the invention, steps are taken to keep power usage to a minimum. When the serial port is enabled a charge pump in the PDA 200's RS232 interface chip uses a lot of power. To reduce power consumption the biosensor program 207 will briefly enable the serial port to moni-tor the clear to send (CTS) line. The CTS line is used to detect if the test module has been disconnected; to indicate when an error has occurred in the test module;
to indicate when a sample has been applied to the test sensor; and to indicate a test complete.
In FIG. 5, a strip is inserted as indicated in a block 500. Initial offset, reference and temperature readings are taken as indicated in a block 502. Then
FIG. 5 illustrates exemplary sequential timing steps performed by the biosensor apparatus 100 in accor-dance with the present invention. In accordance with features of the invention, steps are taken to keep power usage to a minimum. When the serial port is enabled a charge pump in the PDA 200's RS232 interface chip uses a lot of power. To reduce power consumption the biosensor program 207 will briefly enable the serial port to moni-tor the clear to send (CTS) line. The CTS line is used to detect if the test module has been disconnected; to indicate when an error has occurred in the test module;
to indicate when a sample has been applied to the test sensor; and to indicate a test complete.
In FIG. 5, a strip is inserted as indicated in a block 500. Initial offset, reference and temperature readings are taken as indicated in a block 502. Then
-9-waiting for a sample to be applied or threshold is per-formed as indicated in a block 504. Then the CTS line is toggled from low to high as indicated in a block 506.
At a first set time, such as 16 seconds, an offset read-ing is taken as indicated in a block 508. At a second set time, such as 14 seconds, a reference reading is taken as indicated in a block 510. At a third set time, such as 12 seconds, a temperature reading is taken as indicated in a block 512. At a fourth set time, such as seconds, the voltage shunt 124 in the biosensor appa-ratus 100 is turned on as indicated in a block 514. At a fifth set time, such as 1 second, the voltage shunt 124 in the biosensor apparatus 100 is turned off as in-dicated in a block 516. Finally, at 0 seconds, the sen-sor reading is, takes and a glucose reading is computed as indicated in a block 518. The data is sent to the' PDA 200 as indicated in a block 520. Then the biosensor apparatus 100 is shutdown as indicated in a block 522.
In accordance with features of the invention, steps are taken to maintain critical test timing. It is im-portant to keep the user from wasting a'strip. Because of the critical timing of the test countdown and the de-sire not to waste a strip, it is important to remain in the meter and communications program 131 while waiting for sample and during test countdown. Therefore exter-nal PDA 200 system interrupts are either ignored or de-layed, for example, system timers, button presses, menu choices, or the power off button. Because the test tim-ing is critical therefore the biosensor apparatus 100 handles all of the test timing and does not rely on the PDA 200. To conserve power the biosensor apparatus 100 is only turned on when a strip is inserted. The biosen-sor apparatus 100 generates an interrupt to wake up the PDA 200 so that the PDA 200 does not need to be running prior to the insertion of a strip. When a test has com-pleted or when an error has occurred the biosensor appa-
At a first set time, such as 16 seconds, an offset read-ing is taken as indicated in a block 508. At a second set time, such as 14 seconds, a reference reading is taken as indicated in a block 510. At a third set time, such as 12 seconds, a temperature reading is taken as indicated in a block 512. At a fourth set time, such as seconds, the voltage shunt 124 in the biosensor appa-ratus 100 is turned on as indicated in a block 514. At a fifth set time, such as 1 second, the voltage shunt 124 in the biosensor apparatus 100 is turned off as in-dicated in a block 516. Finally, at 0 seconds, the sen-sor reading is, takes and a glucose reading is computed as indicated in a block 518. The data is sent to the' PDA 200 as indicated in a block 520. Then the biosensor apparatus 100 is shutdown as indicated in a block 522.
In accordance with features of the invention, steps are taken to maintain critical test timing. It is im-portant to keep the user from wasting a'strip. Because of the critical timing of the test countdown and the de-sire not to waste a strip, it is important to remain in the meter and communications program 131 while waiting for sample and during test countdown. Therefore exter-nal PDA 200 system interrupts are either ignored or de-layed, for example, system timers, button presses, menu choices, or the power off button. Because the test tim-ing is critical therefore the biosensor apparatus 100 handles all of the test timing and does not rely on the PDA 200. To conserve power the biosensor apparatus 100 is only turned on when a strip is inserted. The biosen-sor apparatus 100 generates an interrupt to wake up the PDA 200 so that the PDA 200 does not need to be running prior to the insertion of a strip. When a test has com-pleted or when an error has occurred the biosensor appa-
-10-ratus 100 is shutdown immediately after reporting its status to the PDA 200. However, the PDA 200 will remain on. The system 10 has the capability of allowing the PDA 200 to wake up the biosensor apparatus 100 by as-serting the data terminal ready (DTR) line. The commu-nication protocol, as illustrated and described with re-spect to FIGS. 6-16, was designed to keep the power us-age by both the PDA 200 and the biosensor apparatus 100 to a minimum.
FIGS. 6-13 are flow charts illustrating exemplary sequential steps performed by the personal data assis-tant 200 in accordance with the present invention. Re-ferring to FIG. 6, PDA 200 waits for a message B from the biosensor apparatus 100 or timeout as indicated in a block 600. The message B provides a software version number and reference method for the biosensor apparatus 100. Checking whether message B has arrived is per-formed as indicated in a decision block 602. If message B has not arrived, then the biosensor application is terminated as indicated in a block 604. Then the modem hotsync application is run as indicated in a block 606.
When the message B has arrived, then a message C is sent to the biosensor apparatus 100 as indicated in a block 608. The message C is a query for a type of test strip.
Next waiting for a message D from the biosensor appara-tus 100 or a timeout is performed as indicated in a block 610. Checking whether message D has arrived is performed as indicated in a decision block 612. If mes-sage D has not arrived, then an error message is dis-played as indicated in a block 614. Next waiting for the user to tap an OK button is performed as indicated in a block 616. Then the logbook screen is displayed as indicated in a block 618. If message D has arrived, then checking for a type of message D is performed as indicated in a block 620. With an error message, se-quential operations continue following entry point A in I t.
FIGS. 6-13 are flow charts illustrating exemplary sequential steps performed by the personal data assis-tant 200 in accordance with the present invention. Re-ferring to FIG. 6, PDA 200 waits for a message B from the biosensor apparatus 100 or timeout as indicated in a block 600. The message B provides a software version number and reference method for the biosensor apparatus 100. Checking whether message B has arrived is per-formed as indicated in a decision block 602. If message B has not arrived, then the biosensor application is terminated as indicated in a block 604. Then the modem hotsync application is run as indicated in a block 606.
When the message B has arrived, then a message C is sent to the biosensor apparatus 100 as indicated in a block 608. The message C is a query for a type of test strip.
Next waiting for a message D from the biosensor appara-tus 100 or a timeout is performed as indicated in a block 610. Checking whether message D has arrived is performed as indicated in a decision block 612. If mes-sage D has not arrived, then an error message is dis-played as indicated in a block 614. Next waiting for the user to tap an OK button is performed as indicated in a block 616. Then the logbook screen is displayed as indicated in a block 618. If message D has arrived, then checking for a type of message D is performed as indicated in a block 620. With an error message, se-quential operations continue following entry point A in I t.
-11-FIG. 7. With a test strip message, sequential opera-tions continue following entry point B in FIG. 7. With a code strip message, sequential operations continue following entry point C in FIG. 12.
Referring to FIG. 7 following entry point A, an er-ror from the module biosensor apparatus 100 is processed as indicated in a block 702. An error message is dis-played as indicated in a block 704. Waiting for user to tap an OK button is performed as indicated in a block 706. Then the logbook screen is displayed as indicated in a block 708. Otherwise for a test strip message fol-lowing entry point B, the test strip message is proc-essed as indicated in a block 710. Checking whether the battery in the biosensor apparatus is dead is performed as indicated in a decision block 712. If the battery is dead, then an error message is displayed as indicated in a block 714. Waiting for user to tap an OK button is performed as indicated in a block 716. Then the logbook screen is displayed as indicated in a block 718. If the battery is not dead, then checking whether the tempera-ture is out of range as indicated in a decision block 720. If the temperature is out of range, then an error message is displayed as indicated in a block 722. Wait-ing for user to tap an OK button is performed as indi-cated in a block 724. Then the logbook screen is dis-played as indicated in a block 726. If the temperature is in range, then a test screen is displayed with a blinking blood drop and enabling the user to change the test strip code F# as indicated in a block 728. Then the sequential operations continue following entry point D in FIG. 8.
Referring to FIG. 8, following entry point D check-ing for a low battery status is performed as indicated in a decision block 802. If a low battery is identi-fied, then a low battery indicator is displayed as indi-
Referring to FIG. 7 following entry point A, an er-ror from the module biosensor apparatus 100 is processed as indicated in a block 702. An error message is dis-played as indicated in a block 704. Waiting for user to tap an OK button is performed as indicated in a block 706. Then the logbook screen is displayed as indicated in a block 708. Otherwise for a test strip message fol-lowing entry point B, the test strip message is proc-essed as indicated in a block 710. Checking whether the battery in the biosensor apparatus is dead is performed as indicated in a decision block 712. If the battery is dead, then an error message is displayed as indicated in a block 714. Waiting for user to tap an OK button is performed as indicated in a block 716. Then the logbook screen is displayed as indicated in a block 718. If the battery is not dead, then checking whether the tempera-ture is out of range as indicated in a decision block 720. If the temperature is out of range, then an error message is displayed as indicated in a block 722. Wait-ing for user to tap an OK button is performed as indi-cated in a block 724. Then the logbook screen is dis-played as indicated in a block 726. If the temperature is in range, then a test screen is displayed with a blinking blood drop and enabling the user to change the test strip code F# as indicated in a block 728. Then the sequential operations continue following entry point D in FIG. 8.
Referring to FIG. 8, following entry point D check-ing for a low battery status is performed as indicated in a decision block 802. If a low battery is identi-fied, then a low battery indicator is displayed as indi-
-12-cated in a block 804. Next checking for a marginal tem-perature status is performed as indicated in a decision block 806. If a marginal temperature is identified, then a marginal temperature indicator is displayed a's indicated in a block 808. Then the CTS line is moni-tored on a set time interval, such as every 1/4 second as indicated in a block 810. Waiting for a timeout, such as 3 minutes or the CTS line to go low; with a user applied sample or an error for the module disconnected from the PDA as indicated in a block 812. Checking whether the CTS line is low is performed as indicated in a decision block 814. If the CTS line is not low, then an error message is displayed as indicated in a block 816. Waiting for user to tap an OK button is performed as indicated in a block 818. Then the logbook screen is displayed as indicated in a block 820. If the CTS line is low, then a message E is sent to query the biosensor apparatus whether the test has started as indicated in a block 822. Then waiting for a message F from the bio-sensor apparatus or a timeout is performed as indicated in a block 824. Checking whether message F has arrived is performed as indicated in a decision block 826. When the message F is not identified, then an error message is displayed as indicated in a block 828. Waiting for the user to-tap OK button is performed as indicated in a block 830. Then the logbook screen is displayed as in-dicated in a block 832. When the message F is identi-fied, then the sequential operations continue following entry point E in FIG. 9.
In FIG. 9, a type of message F is identified as in-dicated in a block 902. An error from the module is processed as indicated in a block 904. An error message is displayed as indicated in a block 906. Waiting for user to tap an OK button is performed as indicated in a block 908. Then the logbook screen is displayed as in-dicated in a block 910. Otherwise for a test started ~ (.
In FIG. 9, a type of message F is identified as in-dicated in a block 902. An error from the module is processed as indicated in a block 904. An error message is displayed as indicated in a block 906. Waiting for user to tap an OK button is performed as indicated in a block 908. Then the logbook screen is displayed as in-dicated in a block 910. Otherwise for a test started ~ (.
-13-message is processed as indicated in a block 912. A
test countdown screen is displayed as indicated in a block 914. The CTS line is monitored, for example every quarter second as indicated in a block 916. Then wait-ing for a timeout, such as 35 seconds or the CTS line to go low for a completed test, an error in the module, or module disconnected from the PDA is performed as indi-cated in a block 918. Then checking whether the CTS
line is low is performed as indicated in a decision block 920. If the CTS line is not low, then an error message is displayed as indicated in a block 922. Wait-ing for user to tap an OK button is performed as indi-cated in a block 924. Then the logbook screen is dis-played as indicated in a block 926. If the CTS line is low, then a message G is sent as indicated in a block 928. Message G is a command and data message type for storing the F# (program #) in the biosensor apparatus.
Sequential operations continue following entry point F
in FIG. 10.
Referring to FIG. 10, next a message H is sent to query the module for the test value as indicated in a block 1000. Waiting for a message I response and the test value data is performed as indicated in a block 1002. Checking whether the message I has arrived is performed as indicated in a decision block 1004. When the message I has not arrived, then an error message is displayed as indicated in a block 1006. Waiting for user to tap an OK button is performed as indicated in a block 1008. Then the logbook screen is displayed as in-dicated in a block 1010. When the message I has ar-rived, then the type of message I is identified as indi-cated in a block 1012. An error from the module is processed as indicated in a block 1014. Then an error message is displayed as indicated in a block 1016.
Waiting for user to tap an OK button is performed as in-dicated in a block 1018. Then the logbook screen is {
test countdown screen is displayed as indicated in a block 914. The CTS line is monitored, for example every quarter second as indicated in a block 916. Then wait-ing for a timeout, such as 35 seconds or the CTS line to go low for a completed test, an error in the module, or module disconnected from the PDA is performed as indi-cated in a block 918. Then checking whether the CTS
line is low is performed as indicated in a decision block 920. If the CTS line is not low, then an error message is displayed as indicated in a block 922. Wait-ing for user to tap an OK button is performed as indi-cated in a block 924. Then the logbook screen is dis-played as indicated in a block 926. If the CTS line is low, then a message G is sent as indicated in a block 928. Message G is a command and data message type for storing the F# (program #) in the biosensor apparatus.
Sequential operations continue following entry point F
in FIG. 10.
Referring to FIG. 10, next a message H is sent to query the module for the test value as indicated in a block 1000. Waiting for a message I response and the test value data is performed as indicated in a block 1002. Checking whether the message I has arrived is performed as indicated in a decision block 1004. When the message I has not arrived, then an error message is displayed as indicated in a block 1006. Waiting for user to tap an OK button is performed as indicated in a block 1008. Then the logbook screen is displayed as in-dicated in a block 1010. When the message I has ar-rived, then the type of message I is identified as indi-cated in a block 1012. An error from the module is processed as indicated in a block 1014. Then an error message is displayed as indicated in a block 1016.
Waiting for user to tap an OK button is performed as in-dicated in a block 1018. Then the logbook screen is {
-14-displayed as indicated in a block 1020. Otherwise, a glucose value is processed as indicated in a block 1022.
Next checking whether the module battery is dead is per-formed as indicated in a block 1024. If the module bat-tery is dead, then an error message is displayed as in-dicated in a block 1026. Waiting for user to tap an OK
button is performed as indicated in a block 1028. Then the logbook screen is displayed as indicated in a block 1030. If the module battery is not dead, then checking whether the module temperature is out of range as indi-cated in a decision block 1032. If the module tempera-ture is out of range, then sequential operations con-tinue following entry point G in FIG. 11. If the module temperature is not out of range, then sequential opera-tions continue following entry point H in FIG. 11.
Referring to FIG. 11, following entry point G an error message is displayed as indicated in a block 1102.
Waiting for user to tap an OK button is performed as in-dicated in a block 1104.. Then the logbook screen is displayed as indicated in a block 1106. Following entry point H the glucose value is displayed as indicated in a block 1108. Checking for a low battery is performed as indicated in a decision block 1110. If a low battery is identified, then a low battery indicator is displayed as indicated in a block 1112. Checking for a marginal tem-perature is performed as indicated in a decision block 1114. If a marginal temperature is identified, then a marginal temperature indicator is displayed as indicated in a block 1116. Next waiting for the user to tap a DONE button is performed as indicated in a block 1118.
The glucose record is stored as indicated in a block 1120. Then the logbook screen is displayed as indicated in a block 1120.
Referring to FIG. 12, following entry point C after a code strip message type is identified at block 620 in
Next checking whether the module battery is dead is per-formed as indicated in a block 1024. If the module bat-tery is dead, then an error message is displayed as in-dicated in a block 1026. Waiting for user to tap an OK
button is performed as indicated in a block 1028. Then the logbook screen is displayed as indicated in a block 1030. If the module battery is not dead, then checking whether the module temperature is out of range as indi-cated in a decision block 1032. If the module tempera-ture is out of range, then sequential operations con-tinue following entry point G in FIG. 11. If the module temperature is not out of range, then sequential opera-tions continue following entry point H in FIG. 11.
Referring to FIG. 11, following entry point G an error message is displayed as indicated in a block 1102.
Waiting for user to tap an OK button is performed as in-dicated in a block 1104.. Then the logbook screen is displayed as indicated in a block 1106. Following entry point H the glucose value is displayed as indicated in a block 1108. Checking for a low battery is performed as indicated in a decision block 1110. If a low battery is identified, then a low battery indicator is displayed as indicated in a block 1112. Checking for a marginal tem-perature is performed as indicated in a decision block 1114. If a marginal temperature is identified, then a marginal temperature indicator is displayed as indicated in a block 1116. Next waiting for the user to tap a DONE button is performed as indicated in a block 1118.
The glucose record is stored as indicated in a block 1120. Then the logbook screen is displayed as indicated in a block 1120.
Referring to FIG. 12, following entry point C after a code strip message type is identified at block 620 in
-15-FIG. 6, the code strip message is processed as indicated in a block 1202. Checking whether the battery in the biosensor apparatus is dead is performed as indicated in a decision block 1204. If the battery is dead, then an error message is displayed as indicated in a block 1206.
Waiting for user to tap an OK button is performed as in-dicated in a block 1208. Then the logbook screen is displayed as indicated in a block 1210. If the battery is not dead, then checking whether the temperature is out of range as indicated in a decision block 1212. if the temperature is out of range, then an error message is displayed as indicated in a block 1214. Waiting for user to tap an OK button is performed as indicated in a block 1216. Then the logbook screen is displayed as in-dicated in a block 1218. If the temperature is not out of range, then a test screen is displayed without the blinking blood drop and without enabling the user to change the test strip code F# as indicated in a block 1220. Then the sequential operations continue following entry point I in FIG. 13.
Referring to FIG. 13, following entry point I
checking for a low battery status is performed as indi-cated in a decision block 1302. If a low battery is identified, then a low battery indicator is displayed as indicated in a block 1304. Next checking for a marginal temperature status is performed as indicated in a deci-sion block 1306. If a marginal temperature is identi-fied, then a marginal temperature indicator is displayed as indicated in a block 1308.' Waiting for a timeout;
the user to turn of f the PDA; or the user to select an-other application is performed as indicated in a block 1312.. Then the display returns to the logbook screen as indicated in a block 1314. Then the user turns off the PDA or runs another application as indicated in a block 1316.
Waiting for user to tap an OK button is performed as in-dicated in a block 1208. Then the logbook screen is displayed as indicated in a block 1210. If the battery is not dead, then checking whether the temperature is out of range as indicated in a decision block 1212. if the temperature is out of range, then an error message is displayed as indicated in a block 1214. Waiting for user to tap an OK button is performed as indicated in a block 1216. Then the logbook screen is displayed as in-dicated in a block 1218. If the temperature is not out of range, then a test screen is displayed without the blinking blood drop and without enabling the user to change the test strip code F# as indicated in a block 1220. Then the sequential operations continue following entry point I in FIG. 13.
Referring to FIG. 13, following entry point I
checking for a low battery status is performed as indi-cated in a decision block 1302. If a low battery is identified, then a low battery indicator is displayed as indicated in a block 1304. Next checking for a marginal temperature status is performed as indicated in a deci-sion block 1306. If a marginal temperature is identi-fied, then a marginal temperature indicator is displayed as indicated in a block 1308.' Waiting for a timeout;
the user to turn of f the PDA; or the user to select an-other application is performed as indicated in a block 1312.. Then the display returns to the logbook screen as indicated in a block 1314. Then the user turns off the PDA or runs another application as indicated in a block 1316.
-16-FIGS. 14-16 are flow charts illustrating exemplary sequential steps performed by the biosensor apparatus 100 in accordance with the present invention. Referring to FIG. 14, first the biosensor apparatus 100 sends a message B to the PDA as indicated in a block 1402. Mes-sage B provides a software version number. The biosen-sor apparatus 100 waits for the message C, query for type of test strip, from the PDA ora timeout as indi-cated in a block 1404. Checking whether message C has arrived is performed as indicated in a decision block 1406. When message C has not arrived, then the biosen-sor apparatus 100 is shut down as indicated in a block 1408. When message C has arrived, then the biosensor apparatus 100 sends message D as indicated in a block 1410. When an error and error code is sent as indicated in a block 1412, then the biosensor apparatus 100 is shut down as indicated in a block 1414. When a code strip response is sent as indicated in a block 1416, then the biosensor apparatus 100 is shut down as indi-cated in a block 1418. When a test strip response is sent as indicated in a block 1420, then the CTS line is set to high as indicated in a block 1422. Then the bio-sensor apparatus 100 waits for a timeout, such as after three minutes or for the user to apply a sample as indi-cated in a block 1424. Checking for a user applied sam-ple is performed as indicated in a decision block 1426.
When a user applied sample is not identified, then the biosensor apparatus 100 is shut down as indicated in a block 1428. When a user applied sample is identified, then the sequential operations continue following entry point J in FIG. 15.
Referring to FIG. 15, after a user applied sample is identified, then the CTS line is set low as indicated in a block 1502. Then the biosensor apparatus 100 waits for a message E or a timeout after a set number of sec-onds as indicated in a block 1504. Checking whether
When a user applied sample is not identified, then the biosensor apparatus 100 is shut down as indicated in a block 1428. When a user applied sample is identified, then the sequential operations continue following entry point J in FIG. 15.
Referring to FIG. 15, after a user applied sample is identified, then the CTS line is set low as indicated in a block 1502. Then the biosensor apparatus 100 waits for a message E or a timeout after a set number of sec-onds as indicated in a block 1504. Checking whether
-17-message E has arrived is performed as indicated in a de-cision block 1506. When message E has not arrived, then the biosensor apparatus 100 is shut down as indicated in a block 1508. When message E has arrived, then the bio-sensor apparatus 100 sets the CTS line high as indicated in a block 1510. The biosensor apparatus 100 sends a message F to the PDA as indicated in a block 1512. Mes-sage F provides an error as indicated in a block 1514.
Then the biosensor apparatus 100 is shut down as indi-cated in a block 1516. Message F indicates that the test has started as indicated in a block 1518. Next the biosensor apparatus 100 waits for the test to complete, or the user to remove sensor or an error to occur as in-dicated in a block 1520. Then the biosensor apparatus 100 sets the CTS line low as indicated in a block 1522.
Next the biosensor apparatus 100 waits for a message G
or timeout as indicated in a block 1524. Then the se-quential operations continue following entry point K in FIG. 16.
Referring to FIG. 16, checking whether message G
has arrived is performed as indicated in a decision block 1602. When message G has not arrived, then the biosensor apparatus 100 is shut down as indicated in a block 1604. When message G has arrived, then the bio-sensor apparatus 100 stores the test strip code F# as indicated in a block 1606. Next the biosensor apparatus 100 waits for a message H from the PDA or a timeout as indicated in a block 1608. Message H is a query for the test value. Checking whether message H has arrived is performed as indicated in a decision block 1610. When message H has not arrived, then the biosensor apparatus 100 is, shut down as indicated in a block 1612. When message H has arrived, then the biosensor apparatus 100 sends a message I as indicated in a block 1614. Message I provides an error as indicated in a block 1616. Then the biosensor apparatus 100 is shut down as indicated in ~
Then the biosensor apparatus 100 is shut down as indi-cated in a block 1516. Message F indicates that the test has started as indicated in a block 1518. Next the biosensor apparatus 100 waits for the test to complete, or the user to remove sensor or an error to occur as in-dicated in a block 1520. Then the biosensor apparatus 100 sets the CTS line low as indicated in a block 1522.
Next the biosensor apparatus 100 waits for a message G
or timeout as indicated in a block 1524. Then the se-quential operations continue following entry point K in FIG. 16.
Referring to FIG. 16, checking whether message G
has arrived is performed as indicated in a decision block 1602. When message G has not arrived, then the biosensor apparatus 100 is shut down as indicated in a block 1604. When message G has arrived, then the bio-sensor apparatus 100 stores the test strip code F# as indicated in a block 1606. Next the biosensor apparatus 100 waits for a message H from the PDA or a timeout as indicated in a block 1608. Message H is a query for the test value. Checking whether message H has arrived is performed as indicated in a decision block 1610. When message H has not arrived, then the biosensor apparatus 100 is, shut down as indicated in a block 1612. When message H has arrived, then the biosensor apparatus 100 sends a message I as indicated in a block 1614. Message I provides an error as indicated in a block 1616. Then the biosensor apparatus 100 is shut down as indicated in ~
-18-a block 1618. Message I indicates a glucose value as indicated in a block 1620. Then the biosensor apparatus 100 is shut down as indicated in a block 1622.
While the present invention has been described with reference to the details of the. embodiments of the in-vention shown in the drawings, these details are not in-tended to limit the scope of the invention as claimed in the appended claims.
While the present invention has been described with reference to the details of the. embodiments of the in-vention shown in the drawings, these details are not in-tended to limit the scope of the invention as claimed in the appended claims.
Claims (16)
1. A system for communications between a biosensor apparatus and a processing device, the system comprising:
a sensor for receiving a user sample to be measured;
a biosensor apparatus that receives the sensor and includes a microcontroller for performing a predefined test sequence that measures a predefined parameter value corresponding to the user sample received by the sensor; and a processing device providing an operator interface, data management, and analysis of biosensor results, wherein in response to the processing device being activated during the predefined test sequence to establish communications between the processing device and the biosensor apparatus, the biosensor apparatus transfers status information to the processing device, and the processing device displays a corresponding message on the operator interface.
a sensor for receiving a user sample to be measured;
a biosensor apparatus that receives the sensor and includes a microcontroller for performing a predefined test sequence that measures a predefined parameter value corresponding to the user sample received by the sensor; and a processing device providing an operator interface, data management, and analysis of biosensor results, wherein in response to the processing device being activated during the predefined test sequence to establish communications between the processing device and the biosensor apparatus, the biosensor apparatus transfers status information to the processing device, and the processing device displays a corresponding message on the operator interface.
2. The system of claim 1, wherein the biosensor apparatus sends the predefined parameter value to the processing device and the processing device displays the predefined parameter value.
3. The system of claim 1, wherein the processing device displays predefined screens for receiving user preferences and user entered records, for editing stored records, for logbook functions, and for analysis and graphical display of biosensor results.
4. The system of claim 1, wherein, in response to the biosensor apparatus receiving the sensor, the biosensor apparatus sends corresponding status information to the processing device.
5. The system of claim 1, wherein the processing device displays predefined screens corresponding to the performance of the predefined test sequence.
6. The system of claim 1, wherein the microcontroller measures an ambient temperature value, and the microcontroller calculates the predefined parameter value utilizing the ambient temperature value.
7. The system of claim 1, wherein the status information includes an error status.
8. The system of claim 7, wherein the microcontroller monitors battery status and temperature status for identifying the error status.
9. A method for implementing communications between a biosensor apparatus and a processing device comprising the steps of:
receiving, with a biosensor apparatus, a sensor that receives a user sample;
performing, with the biosensor apparatus, a predefined test sequence, the biosensor apparatus including a microcontroller that measures, during the predefined test sequence, a predefined parameter value corresponding to the user sample;
activating the processing device during the predefined test sequence to establish communications between the processing device and the biosensor apparatus;
transferring, from the biosensor apparatus, status information to a processing device, the processing device providing an operator interface, data management, and analysis of biosensor results; and displaying, on the operator interface of the processing device, a message corresponding to the status information.
receiving, with a biosensor apparatus, a sensor that receives a user sample;
performing, with the biosensor apparatus, a predefined test sequence, the biosensor apparatus including a microcontroller that measures, during the predefined test sequence, a predefined parameter value corresponding to the user sample;
activating the processing device during the predefined test sequence to establish communications between the processing device and the biosensor apparatus;
transferring, from the biosensor apparatus, status information to a processing device, the processing device providing an operator interface, data management, and analysis of biosensor results; and displaying, on the operator interface of the processing device, a message corresponding to the status information.
10. The method of claim 9, further comprising transferring, from the biosensor apparatus, the predefined parameter value to a processing device, and displaying, on the operator interface of the processing device, the predefined parameter value.
11. The method of claim 9, further comprising displaying, with the processing device, predefined screens for receiving user preferences and user entered records, for editing stored records, for logbook functions, and for analysis and graphical display of biosensor results.
12. The method of claim 9, wherein further comprising, on the operator interface of the processing device, predefined screens corresponding to the performance of the predefined test sequence.
13. The method of claim 9, further comprising in response to the biosensor apparatus receiving the sensor, transferring corresponding status information from the biosensor apparatus to the processing device.
14. The method of claim 9, further comprising measuring, with the microcontroller, an ambient temperature value, wherein the microcontroller calculates the predefined parameter value utilizing the ambient temperature value.
15. The method of claim 9, wherein the status information includes an error status.
16. The method of claim 15, wherein further comprising monitoring, with the microcontroller, battery status and temperature status to identify the error status.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21196400P | 2000-06-16 | 2000-06-16 | |
| US60/211,964 | 2000-06-16 | ||
| CA2349021A CA2349021C (en) | 2000-06-16 | 2001-05-29 | System, method and biosensor apparatus for data communications with a personal data assistant |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2349021A Division CA2349021C (en) | 2000-06-16 | 2001-05-29 | System, method and biosensor apparatus for data communications with a personal data assistant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2689656A1 true CA2689656A1 (en) | 2001-12-16 |
Family
ID=22788977
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2689656A Abandoned CA2689656A1 (en) | 2000-06-16 | 2001-05-29 | System, method and biosensor apparatus for data communications with a personal data assistant |
| CA2349021A Expired - Fee Related CA2349021C (en) | 2000-06-16 | 2001-05-29 | System, method and biosensor apparatus for data communications with a personal data assistant |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2349021A Expired - Fee Related CA2349021C (en) | 2000-06-16 | 2001-05-29 | System, method and biosensor apparatus for data communications with a personal data assistant |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6604050B2 (en) |
| EP (2) | EP2302546A1 (en) |
| JP (1) | JP4804652B2 (en) |
| AU (1) | AU767994B2 (en) |
| CA (2) | CA2689656A1 (en) |
Families Citing this family (122)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7885697B2 (en) | 2004-07-13 | 2011-02-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
| US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
| US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US7025425B2 (en) * | 2000-03-29 | 2006-04-11 | University Of Virginia Patent Foundation | Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US20020087603A1 (en) * | 2001-01-02 | 2002-07-04 | Bergman Eric D. | Change tracking integrated with disconnected device document synchronization |
| US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
| JP4498636B2 (en) | 2001-04-27 | 2010-07-07 | 日本サーモスタット株式会社 | Thermostat device |
| US7103578B2 (en) * | 2001-05-25 | 2006-09-05 | Roche Diagnostics Operations, Inc. | Remote medical device access |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| ATE497731T1 (en) | 2001-06-12 | 2011-02-15 | Pelikan Technologies Inc | DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK |
| EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| JP4149911B2 (en) | 2001-06-12 | 2008-09-17 | ペリカン テクノロジーズ インコーポレイテッド | Electric lancet actuator |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
| US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| JP2004538078A (en) * | 2001-08-20 | 2004-12-24 | インバネス・メディカル・リミテッド | Wireless diabetes management device and method of using wireless diabetes management device |
| US7794994B2 (en) * | 2001-11-09 | 2010-09-14 | Kemeta, Llc | Enzyme-based system and sensor for measuring acetone |
| MXPA04004389A (en) * | 2001-11-09 | 2004-08-12 | Dow Global Technologies Inc | Hand-held medical apparatus. |
| US7225280B2 (en) * | 2002-02-28 | 2007-05-29 | Sandisk Il Ltd. | Portable device for one-on-one transfer between another such device wherein device is restricted to data storage and transfer with single interface for data exchange |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| JP4625693B2 (en) * | 2002-05-08 | 2011-02-02 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | System for diagnosis and / or analysis in clinical practice |
| ES2384558T3 (en) | 2002-09-11 | 2012-07-06 | Becton Dickinson And Company | Blood glucose monitoring including convenient visual presentation of averages and measurement values |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
| EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
| WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
| US20050137573A1 (en) * | 2003-12-19 | 2005-06-23 | Animas Corporation | System, method, and communication hub for controlling external infusion device |
| US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
| WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
| EP1810185A4 (en) | 2004-06-04 | 2010-01-06 | Therasense Inc | Diabetes care host-client architecture and data management system |
| US7422892B2 (en) * | 2004-10-06 | 2008-09-09 | Agentase, Llc | Enzyme-based device for environmental monitoring |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| US8251904B2 (en) | 2005-06-09 | 2012-08-28 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
| DE502005005814D1 (en) * | 2005-07-14 | 2008-12-11 | Mettler Toledo Ag | Signal transmission device for a measuring probe and transmission method |
| KR20080074099A (en) * | 2005-09-12 | 2008-08-12 | 이모티브 시스템즈 피티와이 엘티디. | Detection of and interaction using mental states |
| US7865235B2 (en) | 2005-09-12 | 2011-01-04 | Tan Thi Thai Le | Method and system for detecting and classifying the mental state of a subject |
| US7723120B2 (en) * | 2005-10-26 | 2010-05-25 | General Electric Company | Optical sensor array system and method for parallel processing of chemical and biochemical information |
| US8133741B2 (en) | 2005-10-26 | 2012-03-13 | General Electric Company | Methods and systems for delivery of fluidic samples to sensor arrays |
| US9149215B2 (en) * | 2005-12-30 | 2015-10-06 | Roche Diabetes Care, Inc. | Portable analytical device |
| CA2636174C (en) * | 2006-01-05 | 2022-07-05 | University Of Virginia Patent Foundation | Method, system and computer program product for evaluation of blood glucose variability in diabetes from self-monitoring data |
| US20070276197A1 (en) * | 2006-05-24 | 2007-11-29 | Lifescan, Inc. | Systems and methods for providing individualized disease management |
| US20090312638A1 (en) * | 2006-07-17 | 2009-12-17 | Signostics Pty Ltd | medical diagnostic device |
| US20080154513A1 (en) * | 2006-12-21 | 2008-06-26 | University Of Virginia Patent Foundation | Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes |
| EP2109394B1 (en) | 2007-01-23 | 2018-05-23 | Ascensia Diabetes Care Holdings AG | Analyte-testing device |
| US20080235053A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Communication medium for diabetes management |
| US8758245B2 (en) * | 2007-03-20 | 2014-06-24 | Lifescan, Inc. | Systems and methods for pattern recognition in diabetes management |
| US20080234943A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Computer program for diabetes management |
| USD612279S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland Limited | User interface in an analyte meter |
| US20090240127A1 (en) * | 2008-03-20 | 2009-09-24 | Lifescan, Inc. | Methods of determining pre or post meal time slots or intervals in diabetes management |
| IL197532A0 (en) | 2008-03-21 | 2009-12-24 | Lifescan Scotland Ltd | Analyte testing method and system |
| USD612275S1 (en) | 2008-03-21 | 2010-03-23 | Lifescan Scotland, Ltd. | Analyte test meter |
| USD615431S1 (en) | 2008-03-21 | 2010-05-11 | Lifescan Scotland Limited | Analyte test meter |
| USD611853S1 (en) | 2008-03-21 | 2010-03-16 | Lifescan Scotland Limited | Analyte test meter |
| US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
| USD611151S1 (en) | 2008-06-10 | 2010-03-02 | Lifescan Scotland, Ltd. | Test meter |
| CN104458847A (en) * | 2008-07-07 | 2015-03-25 | 埃葛梅崔克斯股份有限公司 | Integrated blood glucose measurement device |
| USD611489S1 (en) | 2008-07-25 | 2010-03-09 | Lifescan, Inc. | User interface display for a glucose meter |
| USD611372S1 (en) | 2008-09-19 | 2010-03-09 | Lifescan Scotland Limited | Analyte test meter |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
| US20100249965A1 (en) * | 2009-03-31 | 2010-09-30 | Agamatrix, Inc. | Integrated Blood Glucose Measurement Device |
| US20100331645A1 (en) * | 2009-06-25 | 2010-12-30 | Roche Diagnostics Operations, Inc. | Methods and systems for wireless communication between a blood glucose meter and a portable communication device |
| CA3096110C (en) | 2010-03-24 | 2023-11-14 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US10201296B2 (en) | 2010-11-11 | 2019-02-12 | Ascensia Diabetes Care Holdings Ag | Apparatus, systems, and methods adapted to transmit analyte data having common electronic architecture |
| EP2492831A1 (en) * | 2011-02-10 | 2012-08-29 | Pensiero Medical Electronics Corp. | Biomedical device with near field communication (NFC) function and method thereof for user identification, biomedical data measurement, biomedical data upload/download, biomedical data management, and remote medical care |
| EP2491855A1 (en) * | 2011-02-23 | 2012-08-29 | Pensiero Medical Electronics Corp. | Biomedical device capable of using an earphone and microphone plug to transmit data and method for transmitting data |
| US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| US20130076533A1 (en) * | 2011-09-26 | 2013-03-28 | Wireless Medical Ltd. | Data processor for online biometric monitoring |
| US10383580B2 (en) | 2012-12-31 | 2019-08-20 | Abbott Diabetes Care Inc. | Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance |
| US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
| ES2808658T3 (en) | 2013-03-15 | 2021-03-01 | Abbott Point Of Care Inc | Management system for tests at the point of care |
| CA2895538A1 (en) | 2013-03-15 | 2014-09-18 | Abbott Diabetes Care Inc. | System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk |
| EP3797680A1 (en) | 2014-01-10 | 2021-03-31 | Ascensia Diabetes Care Holdings AG | Setup synchronization apparatus and methods for end user medical devices |
| EP3129777B1 (en) | 2014-04-11 | 2023-08-16 | Ascensia Diabetes Care Holdings AG | Wireless transmitter adapters for battery-operated biosensor meters and methods of providing same |
| CA2954503A1 (en) | 2014-07-07 | 2016-01-14 | Ascensia Diabetes Care Holdings Ag | Methods and apparatus for improved device pairing with a dual use piezoelectric acoustic component and vibration sensor |
| US11361863B2 (en) | 2015-04-29 | 2022-06-14 | Ascensia Diabetes Care Holdings Ag | Location-based wireless diabetes management systems, methods and apparatus |
| US11062333B2 (en) * | 2016-11-22 | 2021-07-13 | Accenture Global Solutions Limited | Determining indices based on area-assigned data elements |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5279294A (en) * | 1985-04-08 | 1994-01-18 | Cascade Medical, Inc. | Medical diagnostic system |
| US5258906A (en) * | 1988-07-13 | 1993-11-02 | Vital Heart Systems, Inc. | System for remotely authorizing operation of a device and for automatically generating an invoice based on device usage |
| US5956501A (en) * | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
| US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
| US5704366A (en) * | 1994-05-23 | 1998-01-06 | Enact Health Management Systems | System for monitoring and reporting medical measurements |
| US5528248A (en) * | 1994-08-19 | 1996-06-18 | Trimble Navigation, Ltd. | Personal digital location assistant including a memory cartridge, a GPS smart antenna and a personal computing device |
| FI2607U1 (en) * | 1996-06-17 | 1996-09-27 | Nokia Mobile Phones Ltd | An additional unit designed to be connected to a digital cordless telephone |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| JPH11272375A (en) * | 1998-03-18 | 1999-10-08 | Sony Corp | Communication method between plural electronic instruments |
| DE69937962T2 (en) * | 1998-10-02 | 2008-12-24 | International Business Machines Corp. | DEVICE AND METHOD FOR PROVIDING NETWORK COORDINATED CONVERSION SERVICES |
| AU7715500A (en) * | 1999-09-24 | 2001-04-30 | Healthetech, Inc. | Physiological monitor and associated computation, display and communication unit |
-
2001
- 2001-05-29 CA CA2689656A patent/CA2689656A1/en not_active Abandoned
- 2001-05-29 US US09/865,522 patent/US6604050B2/en not_active Expired - Lifetime
- 2001-05-29 CA CA2349021A patent/CA2349021C/en not_active Expired - Fee Related
- 2001-06-04 AU AU50118/01A patent/AU767994B2/en not_active Ceased
- 2001-06-08 EP EP10183645A patent/EP2302546A1/en not_active Withdrawn
- 2001-06-08 EP EP01114023A patent/EP1164530A3/en not_active Ceased
- 2001-06-15 JP JP2001181516A patent/JP4804652B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU5011801A (en) | 2001-12-20 |
| EP1164530A3 (en) | 2004-12-22 |
| EP2302546A1 (en) | 2011-03-30 |
| US6604050B2 (en) | 2003-08-05 |
| JP4804652B2 (en) | 2011-11-02 |
| AU767994B2 (en) | 2003-11-27 |
| EP1164530A2 (en) | 2001-12-19 |
| US20010056328A1 (en) | 2001-12-27 |
| CA2349021C (en) | 2010-03-30 |
| CA2349021A1 (en) | 2001-12-16 |
| JP2002095653A (en) | 2002-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2349021C (en) | System, method and biosensor apparatus for data communications with a personal data assistant | |
| EP0764469B1 (en) | Method and apparatus for marking predetermined events with a biosensor | |
| CA2430725C (en) | Analyte testing device | |
| US8560250B2 (en) | Method and system for transferring analyte test data | |
| AU2009200129B2 (en) | Analyte testing method and system | |
| US20090216105A1 (en) | Blood glucose tracking apparatus and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20171003 |
|
| FZDE | Discontinued |
Effective date: 20171003 |